Utility of enhanced liver fibrosis and other non-invasive tests in detecting liver fibrosis in patients undergoing bariatric surgery.
BACKGROUND The presence of metabolic dysfunction-associated steatotic liver disease and liver fibrosis in patients with obesity is associated with poor long-term liver-related outcomes. Liver biopsy is the gold standard. The enhanced liver fibrosis (ELF) panel is a non-invasive test (NIT) with an excellent correlation...